Do patients with non-ulcer dyspepsia respond differently to Helicobacter pylori eradication treatments from those with peptic ulcer disease? A systematic review

World Journal of Gastroenterology

Volumn 11, Issue 18, 2005, Pages 2726-2732

  Huang, Jia Qing ^a   Zheng, Ge Fan ^a   Hunt, Richard H ^b   Wong, Wai Man ^a   Lam, Shiu Kum ^a   Karlberg, Johan ^a   Wong, Benjamin Chun Yu ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b MCMASTER UNIVERSITY MEDICAL CENTRE   (Canada)

Author keywords

H pylori eradication; Meta analysis; Non ulcer dyspepsia; Peptic ulcer disease

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; FURAZOLIDONE; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE BISMUTH CITRATE; TETRACYCLINE; TINIDAZOLE;

COMPUTER SYSTEM; DATA ANALYSIS; DATA BASE; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFICACY; DYSPEPSIA; EMBASE; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFORMATION PROCESSING; INTERMETHOD COMPARISON; MEDLINE; METHODOLOGY; OUTCOMES RESEARCH; PEPTIC ULCER; QUALITY CONTROL; REVIEW; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; SYSTEMATIC REVIEW;

EID: 18944364993     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i18.2726     Document Type: Review

References (33)

1. McNulty CA, Gearty JC, Crump B, Davis M, Donovan IA, Melikian V, Lister DM, Wise R. Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Br Med J 1986; 293: 645-649
2. Peterson WL, Fendrick AM, Cave DR, Peura DA, Garabedian-Ruffalo SM, Laine L. Helicobacter pylori-related disease: guidelines for testing and treatment. Arch Intern Med 2000; 160: 1285-1291
3. Lam SK, Talley NJ. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection. J Gastroenterol Hepatol 1998; 13: 1-12
4. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G. Current concepts in the management of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16: 167-180
5. Huang JQ, Hunt RH. Treatment after failure: the problem of "non-responders". Gut 1999; 45(Suppl I): 140-144
6. Gisbert JP, Marcos S, Gisbert JL, Pajares JM. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia. Eur J Gastroenterol Hepatol 2001; 13: 1303-1307
7. Catalano F, Catanzaro R, Brogna A. Duodenal ulcer and functional dyspepsia: different susceptibility of Helicobacter pylori to eradicating therapy. Gastroenterology 1997: 112: A84
8. Gutierrez O, Otero W, Melo M. Helicobacter pylori eradication: duodenal ulcer vs functional dyspepsia. Gastroenterology 1998; 114: A142
9. De Francesco V, Sgarro C, Cela E. Helicobacter pylori Eradication Rates In Non-ulcer Dyspepsia (nud) And Duodenal Ulcer (du) Patients. Gut 2001; 49(Suppl 2): A94
10. Sato J, Yanaka A, Yokota H. High-dose clarithromycin in the eradication of Helicobacter pylori infection. Gastroenterology 1997; 112: A279
11. Zullo A, Vaira D, Vakil N. High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther 2003; 17: 719-726
12. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634
13. De Francesco V, Zullo A, Hassan C, Faleo D, Ierardi E, Panella C, Morini S. Two new treatment regimens for Helicobacter pylori eradication: a randomised study. Dig Liver Dis 2001; 33: 676-679
14. Lu H, Zhang DZ, Hu PJ, Li ZS, Lu XH, Fang XC, Xiao SD. One-week regimens containing ranitidine bismuth citrate, furazolidone and either amoxicillin or tetracycline effectively eradicate Helicobacter pylori: a multicentre, randomized, double-blind study. Aliment Pharmacol Ther 2001; 15: 1975-1979
15. Gisbert JP, Carpio D, Marcos S, Gisbert JL, Garcia Gravalos R, Pajares JM. One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. Eur J Gastroenterol Hepatol 2000; 12: 489-495
16. Sung JJ, Chan FK, Wu JC, Leung WK, Suen R, Ling TK, Lee YT, Cheng AF, Chung SC. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study. Aliment Pharmacol Ther 1999; 13: 1079-1084
17. van Doorn LJ, Schneeberger PM, Nouhan N, Plaisier AP, Quint WG, de Boer WA. Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment. Gut 2000; 46: 321-326
18. Korman MG, Bolin TD, Nicholson FB, Engelman JL. Lansoprazole quadruple therapy is effective in curing Helicobacter pylori infection. Helicobacter 1998; 3: 202-205
19. O'Morain C, Borody T, Farley A. Efficacy and safety of single-triple capsules of bismuth biskalcitrate, metronidazole and tetracycline, given with omeprazole, for the eradication of Helicobacter pylori: an international multicentre study. Aliment Pharmacol Ther 2003; 17: 415-420
20. Luna P, del Castillo G, Farias R. Efficacy and tolerability of a seven-day triple scheme with pantoprazole, amoxicillin and clarithromycin for eradicarion of Helicobacter pylori. Gastroenterology 1997; 112: A202
21. Mantzaris GJ, Archavlis EM, Amberiadis P. Is the Activity and Severity of Gastritis and Helicobacter Pylori Load Related to the Outcome of Anti-H pylori Treastment? Gastroenterology 1998; 114(4 Pt 2): A214
22. Borda F, Martinez A, Elizalde I, Pastor G, Echarri A, Rodriguez A, Does the efficacy of eradication treatment with OCA-7 decrease in non-ulcer gastroduodenal disease? Gut 1999; 45 (Suppl V): A270
23. Bardhan KD, Dillon J, Axon AT, Cooper BT, Tildesley G, Wyatt JI, Gatz G, Braun W. Triple therapy for Helicobacter pylori eradication: a comparison of pantoprazole once versus twice daily. Aliment Pharmacol Ther 2000; 14: 59-67
24. Della Libera E, Rohr MR, Moraes M, Siqueira ES, Ferrari AP Jr. Eradication of Helicobacter pylori infection in patients with duodenal ulcer and non-ulcer dyspepsia and analysis of one-year reinfection rates. Braz J Med Biol Res 2001; 34: 753-757
25. Adamek RJ, Pfaffenbach B, Szymanski C. Cure of H pylori infection using a 7-d triple therapy combining pantoprazole with two antibiotics. Helicobacter 1998; 3: 206-211
26. Bate CM, Keeling PWN, Crowe JP, Axon ATR, Tildesley G, Harris SJ, Powell JA. Effect of Helicobacter pylori eradication in patients with non-ulcer dyspepsia and duodenal ulcer disease using two omeprazole treatment regimens - a 12 mo follow-up study. J Clin Res 1998; 1: 103-118
27. Vakil N, Lanza F, Schwartz H, Barth J. Seven-day therapy for Helicobacter pylori in the United States. Aliment Pharmacol Ther 2004; 20: 99-107
28. Hunt RH, Fallone CA, Thomson AB. Canadian Helicobacter pylori consensus conference update: Infections in adults. Canadian Helicobacter Study Group. Can J Gastroenterol 1999; 13: 213-217
29. Coelho LG, Leon-Barua R, Quigley EM. Latin-American consensus conference on Helicobacter pylori infection. Latin-American National Gastroenterological Societies Affiliated with the Inter-American Association of Gastroenterology (AIGE). Am J Gastroenterol 2000; 95: 2688-2691
30. Gisbert JP, Gonzalez L, Calvet X, Garcia N, Lopez T, Roque M, Gabriel R, Pajares JM. Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori. Aliment Pharmacol Ther 2000; 14: 1319-1328
31. Huang J, Hunt RH. The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole. Aliment Pharmacol Ther 1999; 13: 719-729
32. Houben MHMG, Schraffordt Koops HS, Rauws EAJ, van't Hoff BWM, van der Hulst RWM, van der Ende A, ten Kate FJW, Tytgat GNJ. Efficacy of PPI-triple therapy in H pylori (Hp) positive patients with ulcer disease versus patients with non-ulcer dyspepsia. Gut 1998; 43: A85
33. Kamberoglou D, Sanidas I, Doulgeroglou V, Savva S, Patra E, Tzias V. Efficacy of Helicobacter pylori eradication regimens in functional dyspepsia - comparison with peptic ulcer disease. Gut 2000; 47(Suppl 3): A89